F. Soban

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study.

I. Tannock, G. Pond, R. de Wit, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Factors influencing the use of single vs multiple fractions of palliative radiotherapy for bone metastases: a 5-year review.

G. Pond, A. Bezjak, M. Mclean, 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study.

I. Tannock, G. Pond, R. de Wit, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The success of data collection in the palliative setting—telephone or clinic follow-up?

A. Bezjak, M. Mclean, R. Wong, 2003, Supportive Care in Cancer.